Transfer of chloramphenicol-resistant mitochondrial DNA into the chimeric mouse

Transgenic Research

Volumn 8, Issue 2, 1999, Pages 137-145

  Levy, Shawn E ^a   Waymire, Katrina G ^a   Kim, Yoon L ^a   MacGregor, Grant R ^a   Wallace, Douglas C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chloramphenicol; Cybrid; Embryonic stem cell; Mitochondria; Mouse; Rhodamine 6 G

Indexed keywords

CHIMERIC GENE; DNA TRANSFER; MITOCHONDRIAL DNA;

EID: 0033117377     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008967412955     Document Type: Article

References (28)

1. Blanc H, Wright CT, Bibb MJ, Wallace DC and Clayton DA (1981) Mitochondrial DNA of chloramphenicol-resistant mouse cells contains a single nucleotide change in the region encoding the 3′ end of the large ribosomal RNA. Proc Natl Acad Sci USA 78: 3789-3793.
2. Bullough DA, Ceccarelli EA, Roise D and Allison WS (1989) Inhibition of the bovine-heart mitochondrial F1-ATPase by cationic dyes and amphipathic peptides. Biochim Biophys Acta 975: 377-383.
3. Bunn CL, Wallace DC and Eisenstadt JM (1974) Cytoplasmic inheritance of chlormaphenicol resistance in mouse tissue culture cells. Proc Natl Acad Sci USA 71: 1681-1685.
4. Chen LB (1988) Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 4: 155-181.
5. Ebert KM, Aleivar A, Liem H, Goggins R and Hecht NB (1989) Mouse zygotes injected with mitochondria develop normally but the exogenous mitochondria are not detectable in the progeny. Mol Reprod Dev 1: 156-163.
6. Gear AR (1974) Rhodamine 6G: A potent inhibitor of mitochondrial oxidative phosphorylation. J Biol Chem 249: 3628-3637.
7. Higuti T, Niimi S, Saito R, Nakasima S, Ohe T, Tani I and Yoshimura T (1980) Rhodamine 6G, inhibitor of both H+ ejections from mitochondria energized with ATP and with respiratory substrates. Biochim Biophys Acta 593: 463-467.
8. Jenuth JP, Peterson AC, Fu K and Shoubridge EA (1996) Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA (see comments). Nat Genet 14: 146-151.
9. Jenuth JP, Peterson AC and Shoubridge EA (1997) Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat Genet 16: 93-95.
10. Johnson LV, Walsh ML and Chen LB (1980) Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 77: 990-994.
11. Lampidis TJ, Munck JN, Krishan A and Tapiero H (1985) Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells. Cancer Res 45: 2626-2631.
12. Mai MS and Allison WS (1983). Inhibition of an oligomycin-sensitive ATPase by cationic dyes, some of which are atypical uncouplers of intact mitochondria. Arch Biochem Biophys 221: 467-476.
13. Mannella CA and Wang Q (1989) Permeability of the mitochondrial outer membrane to organic cations. Biochim Biophys Acta 981: 363-366.
14. McMahon AP and Bradley A (1990) The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62: 1073-1085.
15. Meirelles FV and Smith LC (1997) Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation. Genetics 145: 445-451.
16. Meirelles FV and Smith LC (1998) Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos. Genetics 148: 877-883.
17. Pinkert CA, Irwin MH, Johnson LW and Moffatt RJ (1997) Mitochondria transfer into mouse ova by microinjection. Transgenic Res 6: 379-383.
18. Stocco DM (1983) Rapid, quantitative isolation of mitochondria from rat liver using Ficoll gradients in vertical rotors. Anal Biochem 131: 453-457.
19. Trounce I, Neill S and Wallace DC (1994) Cytoplasmic transfer of the mtDNA nt 8993 TG (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc Natl Acad Sci USA 91: 8334-8338.
20. Trounce I and Wallace DC (1996) Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells. Somatic Cell and Molec Gen 22: 81-85.
21. Trounce IA, Kim YL, Jun AS and Wallace DC (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Meth Enzymol 264, 484-509.
22. Wallace DC (1992) Diseases of the mitochondrial DNA. Ann Rev Biochem 61: 1175-1212.
23. Wallace DC, Bunn CL and Eisenstadt JM (1975) Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells. J Cell Biol 67: 174-188.
24. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ and Nikoskelainen EK (1988a) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427-1430.
25. Wallace DC, Zheng X, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM and Hopkins LC (1988b) Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55: 601-610.
26. Watanabe T, Dewey MJ and Mintz B (1978) Teratocarcinoma cells as vehicles for introducing specific mutant mitochondrial genes into mice. Proc Natl Acad Sci USA 75: 5113-5117.
27. Wicker HJ, Kuschmitz D and Hess B (1987) Inhibition of yeast mitochondrial F1-ATPase, F0F1-ATPase and submitochondrial particles by rhodamines and ethidium bromide. Biochim Biophys Acta 892: 108-117.
28. Zheng XX, Shoffner JM, Voljavee AS and Wallace DC (1990) Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochimica et Biophysica Acta 1019: 1-10.